Filing Details
- Accession Number:
- 0001209191-20-064444
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 16:51:58
- Reporting Period:
- 2020-12-16
- Accepted Time:
- 2020-12-18 16:51:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724521 | Arcus Biosciences Inc. | RCUS | Pharmaceutical Preparations (2834) | 473898435 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730229 | William Grossman | C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-16 | 2,117 | $31.35 | 6,727 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- Includes 992 shares purchased on 5/29/2020 and 1,002 shares purchased on 11/30/2020 through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
